Clinical Research

Led by Division Chief Fernando J. Martinez, clinical research within the division has been rapidly expanding. Our research programs range from leading a multi-center, NHLBI-sponsored consortium to identify undiagnosed COPD, to the early identification and defining outcomes in COPD. Similarly, we lead multicenter investigative studies in a broad range of interstitial lung diseases and participate in numerous federal and industry sponsored therapeutic trials. In the intensive care unit, Augustine M.K. Choi is the primary investigator on a phase three randomized trial of inhaled carbon monoxide in patient with acute respiratory distress syndrome. Our outcomes research programs include multiple ICU based studies utilizing our ICU REDCap database to study critically ill patients as well as use of the ARDSnet database to identify sub-phenotypes and endotypes of acute respiratory distress syndrome. Our division maintains a biobank of critical illness, a biobank of patients with concern for sepsis, a biobank of interstitial lung disease patients, as well as a database of endobronchial ultrasound procedures including patient outcomes.

Dr. Kerri Aronson
Kerri Ilene Aronson, M.D.
  • Patient-reported outcomes in Interstitial Lung Disease
  • Studying health-related quality of live and exposure assessments in Hypersensitivity Pneumonitis
Placeholder profile image
Karla V. Ballman, Ph.D.
  • Analysis of high-dimensional data
  • Design of clinical trials
  • Generation of predictive biomarkers
  • Analysis of observational data
Dr. Augustine Choi
Augustine M. K. Choi, M.D.
  • Inhaled CO for the treatment of acute respiratory distress syndrome
Dr. Daniel Fitzgerald
Daniel W. Fitzgerald, M.D.
  • Pathogenesis and treatment of HIV and TB in resource-poor settings
Dr. Marshall Glesby
Marshall J. Glesby, M.D., Ph.D.
  • Pathogenesis and optimization in the management of complications of chronic viral infections
Dr. Kelly Griffin
Kelly Griffin, M.D.
  • Critical care of obstetric patients
  • Critical care of patients with hematologic malignancies
  • Critical care of patients with severe COVID-19
Dr. Deborah Haisch
Deborah Annelle Haisch, M.D.
  • Illness severity scoring
  • Critical care in low-income settings
Dr. Ben-Gary Harvey
BenGary Harvey, M.D.
  • Outcomes in patients undergoing endobronchial ultrasound assisted biopsy
  • Lung cancer
Dr. Robert Kaner
Robert J. Kaner, M.D.
  • Therapeutic trials in IPF
  • Rheumatoid arthritis - interstitial lung disease (RA-ILD), COPD, and emphysema
  • Gene expression in alveolar macrophages
Dr. Jamuna Krishnan
Jamuna Krishnan, M.D., M.B.A.
  • COPD
  • Health care disparities
Dr. Lindsey Lief
Lindsay Lief, M.D.
  • Dignity and identifying suffering in end of life care
Dr. Fernando Martinez
Fernando J Martinez, M.D., M.S.
  • Early identification of COPD
  • Therapeutic trials in COPD
  • Therapeutic trials in IPF
Dr. Michael Niederman
Michael S. Niederman, M.D.
  • New therapies for nosocomial pneumonia
  • Management of pneumonia
Placeholder profile image
Jyotishman Pathak, Ph.D.
  • Informatics methods for data mining
  • Phenotype extraction from electronic medical records
Dr. Anna Podolanczuk
Anna Podolanczuk, M.D.
  • Early identification of ILD/ILA
  • Environmental and cardiovascular risk factors for ILD
Dr. Monika Safford
Monika M Safford, M.D.
  • Preventive healthcare
  • Treatment of acute and chronic illness
  • Coordination of care for those with complex diseases
Dr. Edward Schenck
Edward J. Schenck, M.D.
  • Association between biomarkers of cell death and outcomes in critically ill patients
Placeholder profile image
Ilias Siempos, D.Sc., M.D.
  • Clinical phenotypes in acute respiratory distress syndrome

Pulmonary and Critical Care Medicine

Fernando J. Martinez, M.D., M.S., Chief

Pulmonary and Critical Care Medicine Fellowship

Meredith Turetz, M.D., Program Director
Robert Kaner, M.D., Associate Program Director
Bradley Hayward, M.D., Associate Program Director

Patrycja Golinska, M.S., Program Coordinator
Tel: (646) 962-2738
Fax: (646) 962-0286